Time-restricted Feeding to Reduce Inflammation in Fanconi Anemia
NCT05598515 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3
Last updated 2024-07-24
Summary
The main reason for this research study is to determine whether time-restricted eating will reduce inflammation in the bodies of persons with Fanconi anemia (FA) and whether time-restricted eating will improve function in people with FA and neurological changes. Participants will be asked to eat for only 8 hours out of 24 hours in a day.
Conditions
- Fanconi Anemia
Interventions
- BEHAVIORAL
-
Time-Restricted Feeding
Participants will be asked to eat for only 8 hours out of 24 hours in a day.
Sponsors & Collaborators
-
Children's Hospital Medical Center, Cincinnati
lead OTHER
Principal Investigators
-
Stella Davies, MBBS, PhD, MRCP · Children's Hospital Medical Center, Cincinnati
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-11-11
- Primary Completion
- 2023-12-07
- Completion
- 2023-12-07
Countries
- United States
Study Locations
More Related Trials
-
Study of Initial Steroid Treatment in Young Children With Nephrotic Syndrome
NCT04536181 ·Status: WITHDRAWN ·Phase: PHASE3
-
MR Spectroscopy and Disease Severity Score for Gaucher in Pediatric Population
NCT01397435 ·Status: COMPLETED
-
PET/MRI in the Diagnosis of Pediatric Chronic Pain
NCT04435821 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Rituximab Monotherapy on Children With New-onset Nephrotic Syndrome: A Randomized Controlled Trial
NCT05734794 ·Status: RECRUITING ·Phase: PHASE3
-
Absorption of Corticosteroids in Children With Juvenile Dermatomyositis
NCT00004357 ·Status: COMPLETED ·Phase: PHASE2
-
Steroid Sensitive Nephrotic Syndrome in Children
NCT03878914 ·Status: TERMINATED ·Phase: PHASE4
-
AVN of Weight-Bearing Joints In Patients With Hematologic Malignancies Treated With Dexamethasone Or Prednisone
NCT00719147 ·Status: COMPLETED
-
Placental Lesions in Fetal Growth Restrictions
NCT04839185 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Feraheme As An MRI Contrast Agent For Pediatric Congenital Heart Disease
NCT02752191 ·Status: COMPLETED ·Phase: PHASE4
-
Contrast-enhanced MRI in Children 2 Months to <2 Years
NCT00937391 ·Status: COMPLETED ·Phase: PHASE3
-
Retrospective Study of MRI in Pediatric Patients
NCT02291822 ·Status: COMPLETED
-
Diffusion MRI and Growth Plate Injuries: Pilot Study
NCT01774539 ·Status: UNKNOWN
-
Assessment of a Feeding Difficulties Diagnostic Tool Questionnaire For Children With Oral Feeding Resistance
NCT02377596 ·Status: WITHDRAWN
-
Oxidative Stress, Inflammation and Acute Decompensation in Urea Cycle Disorders
NCT01541722 ·Status: TERMINATED
-
Palliative Care Needs of Children With Rare Diseases and Their Families
NCT06938542 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
The Feasibility, Acceptability and Clinical Utility of a New Remote-mobile Technology Intervention (ASARM) for CFS/ME in a Paediatric Population
NCT02082730 ·Status: COMPLETED ·Phase: NA
-
Identification of Pre-Malignant Lesions In Pediatric Patients With Neurofibromatosis Type 1 Using Novel Magnetic Resonance Imaging Techniques Paired With Artificial Intelligence
NCT04763109 ·Status: RECRUITING ·Phase: NA
-
Feasibility Study: MRI on 6 Months, 1 Year, and 2 Years Old Children Without Sedation
NCT02676960 ·Status: COMPLETED
-
Outcomes Study of Late Effects After Proton RT for Pediatric Tumors of the Brain, Head, and Neck
NCT01067196 ·Status: COMPLETED
-
MR-HIFU Treatment of Painful Osteoid Osteoma
NCT04658771 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Use of Hyperpolarized Xenon Gas for Lung Imaging in Children and Adults
NCT02272049 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Biokinetics Study for Tc-99m MDP in Pediatric Molecular Imaging
NCT03107247 ·Status: COMPLETED
-
Resiliency Training in Adolescents With NF1 and NF2
NCT03873610 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Selumetinib Paediatric NF1 Japan Study
NCT04495127 ·Status: COMPLETED ·Phase: PHASE1
-
Neuroimaging Ancillary Study
NCT05545527 ·Status: COMPLETED